Persistence of concurrent infections with multiple human papillomavirus types: A population-based Cohort Study

Journal of Infectious Diseases

Volumn 203, Issue 6, 2011, Pages 823-827

  Campos, Nicole G ^a   Rodriguez, Ana Cecilia ^b   Castle, Philip E ^c   Herrero, Rolando ^b   Hildesheim, Allan ^c   Katki, Hormuzd ^c   Kim, Jane J ^a   Wacholder, Sholom ^c   Morales, Jorge ^b   Burk, Robert D ^d   Schiffman, Mark ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b PROYECTO EPIDEMIOLÓGICO GUANACASTE   (Costa Rica)

^c NATIONAL CANCER INSTITUTE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONCURRENT INFECTION; CONTROLLED STUDY; COSTA RICA; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PERSISTENT VIRUS INFECTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SURVIVAL TIME; VIRUS DETECTION;

ADOLESCENT; ADULT; COHORT STUDIES; COSTA RICA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECURRENCE; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 79952352493     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq131     Document Type: Article

References (15)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9. (Pubitemid 29406813)
2. Rodriguez AC, Schiffman M, Herrero R, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 2008; 100:513-7.
3. Castle PE, Rodriguez AC, Burk RD, et al. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ 2009; 229:b2569.
4. Schiffman M, Herrero R, DeSalle R, et al. The carcinogenicity of human papillomavirus reflects viral evolution. Virology 2005; 337:76-84. (Pubitemid 40725441)
5. Trottier H, Mahmud S, Prado JCM, et al. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis 2008; 197:1236-47.
6. Liaw K, Hildesheim A, Burk RD, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001; 183:8-15. (Pubitemid 32043036)
7. Muñoz N, Hernandez-Suarez G, Méndez F, et al. Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer 2009; 100:1184-90.
8. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007; 195:1582-9. (Pubitemid 46799215)
9. Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papipllomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191:1796-807. (Pubitemid 40705385)
10. Trottier H, Mahmud S, Costa M, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006; 15:1274-80. (Pubitemid 44125281)
11. Wheeler CM, Hunt WC, Schiffman M, Castle PE. Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Study Group. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis 2006;194:1291-9.
12. Wentzensen N, Schiffman M, Dunn T, et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 2009; 125:2151-8.
13. Herrero R, Schiffman MH, Bratti C, et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste project. Rev Panam Salud Publica 1997; 1:362-75. (Pubitemid 27428425)
14. Castle PE, Schiffman M, Gravitt PE, et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol 2002; 68:417-23.
15. Rodriguez AC, Schiffman M, Herrero R, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst 2010; 102:1-10.